Already 2,838 Mukomuko Residents Receive COVID-19 Vaccine
JAKARTA - The Health Office of Mukomuko Regency, Bengkulu said the number of local residents who had received the first dose of COVID-19 vaccination until Saturday reached 2,838 people.
Mukomuko District COVID-19 Task Force Spokesperson Bustam Bustomo in his statement in Mukomuko, Saturday, June 5 stated that 2,838 residents who had received the first dose of vaccination consisted of 1,236 health workers, 1,516 public service officers, and 86 elderly people (elderly).
He said the 1,516 public service officers who had undergone vaccination consisted of personnel from the Kodim, Polres, Brimob, District Attorney, District Court, KPPN, Religious Courts, journalists, BPJS, government employees, BRI, and state civil servants (ASN) in the local district government. .
A total of 2,221 people who have received a complete injection of COVID-19 vaccination, namely dose I and dose II, consisting of 1,100 health workers, 1,043 public service workers, and 78 elderly.
As of today, there are still 671 health workers, public service workers, and the elderly who have received the first dose of COVID-19 vaccine but have not received the second dose of vaccine because some of them have not yet arrived and their health conditions are not yet possible.
"There are residents who have not received the second dose of COVID-19 vaccine because their health conditions have not allowed it and there are residents who have not yet received the second dose of the COVID-19 vaccine," he said.
He stated that the injection of the COVID-19 vaccine dose I and dose II for health workers, public service workers, and the elderly would continue according to the target number.
Currently, the regional health workers are still waiting for the health conditions of the local residents to recover to receive a complete injection of the COVID-19 vaccine, namely dose I and dose II.
He ensured that there were still stocks of COVID-19 vaccines, both for health workers and public service workers, who had not received either dose I or dose II of the COVID-19 vaccine.